Up-regulation of VLDL receptor expression and its signaling pathway induced by VLDL and β-VLDL

Abstract

Very low density lipoprotein receptor (VLDLR) is thought to participate in the pathogenesis of atherosclerosis induced by VLDL and β-VLDL. The present study was undertaken to elucidate the effects of VLDL and β-VLDL on VLDLR expression and its signaling pathway. RAW264.7 cells were incubated with VLDL and β-VLDL. The expression of VLDLR mRNA was detected by RT-PCR. The transcriptional activity of VLDLR gene was detected in recombinant plasmid pGL4.2VR-luciferase transfected RAW264.7. Western blot assay was used to detect the changes of phosphorylated ERK1/2 protein. Inhibitors or activators were used to observe the signal pathway involving VLDLR expression regulation. The results showed that VLDL and β-VLDL stimulated ERK1/2 activity in a PKC-dependent manner. VLDL or β-VLDL-induced VLDLR expression on macrophages was extremely abolished by inhibitors ERK1/2 or PKC. Our findings revealed that VLDL or β-VLDL-induced VLDLR expression via PKC/ERK cascades and the effect was linked to the transcriptional activation of VLDLR gene promoter.

Keywords

VLDLR / signal transduction / transcriptional regulation

References

[1] MacDougallE.D., KramerF., PolinskyP., et al. . Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficient mice. Am J Pathol, 2006, 168(6): 2064-2073

[2] HiltunenT.P., LuomaJ.S., NikkariT., et al. . Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation, 1998, 97(11): 1079-1086

[3] QuS., WuF., TianJ., et al. . Role of VLDL receptor in the process of foam cell formation. J Huazhong Univ Sci Technol Med Sci, 2004, 24(1): 1-4

[4] TiebelO., OkaK., RobinsonK., et al. . Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation. Atherosclerosis, 1999, 145(2): 239-251

[5] NakazatoK., IshibashiT., NagataK., et al. . Expression of very low density lipoprotein receptor mRNA in circulating human monocytes: its up-regulation by hypoxia. Atherosclerosis, 2001, 155(2): 439-444

[6] EckM.V., OostJ., GoudriaanJ.R., et al. . Role of the macrophage very-low-density lipoprotein receptor in atherosclerotic lesion development. Atherosclerosis, 2005, 183(2): 230-237

[7] Gouni-BertholdI., BertholdH.K., SeulC., et al. . Effects of authentic and VLDL hydrolysis-derived fatty acids on vascular smooth muscle cell growth. Br J Pharmacol, 2001, 132(8): 1725-1734

[8] KawakamiA., TanakaA., ChibaT., et al. . Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation. Circulation, 2003, 108(21): 2679-2688

[9] HoeH.S., RebeckG.W.. Regulation of ApoE receptor proteolysis by ligand binding. Brain Res Mol Brain Res, 2005, 137(1–2): 31-39

[10] ZhaoD., LettermanJ., SchreiberB.M.. Beta-Migrating very low density lipoprotein (beta VLDL) activates smooth muscle cell mitogen-activated protein (MAP) kinase via G protein-coupled receptor-mediated transactivation of the epidermal growth factor (EGF) receptor: effect of MAP kinase activation on beta VLDL plus EGF-induced cell proliferation. J Biol Chem, 2001, 276(33): 30579-33088

[11] SachinidisA., KettenhofenR., SeewaldS., et al. . Evidence that lipoproteins are carriers of bioactive factors. Arterioscler Thromb Vasc Biol, 1999, 19(10): 2412-2421

[12] PedrenoJ., Hurt-CamejoE., WiklundO., et al. . Low-density lipoprotein (LDL) binds to a G-protein coupled receptor in human platelets. Evidence that the proaggregatory effect induced by LDL is modulated by down-regulation of binding sites and desensitization of its mediated signaling. Atherosclerosis, 2001, 155(1): 99-112

[13] BanfiC., MussoniL., RisP., et al. . Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells. Circ Res, 1999, 85(2): 208-217

[14] WebbD.J., ThomasK.S., GoniasS.L.. Plasminogen activator inhibitor 1 functions as a urokinase response modifier at the level of cell signaling and thereby promotes MCF-7 cell growth. J Cell Biol, 2001, 152(4): 741-752

[15] WebbD.J., NguyenD.H., SankovicM., et al. . The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. J Biol Chem, 1999, 274(11): 7412-7420

[16] StrasserV., FaschingD., HauserC., et al. . Receptor clustering is involved in Reelin signaling. Mol Cell Biol, 2004, 24(3): 1378-1386

[17] BockH.H., JossinY., MayP., et al. . Apolipoprotein E receptors are required for reelin-induced proteasomal degradation of the neuronal adaptor protein Disabled-1. J Biol Chem, 2004, 279(32): 33 471-33 479

[18] Shirotani-IkejimaH., KokameK., HamuroT., et al. . Tissue factor pathway inhibitor induces expression of JUNB and GADD45B mRNAs. Biochem Biophys Res Commun, 2002, 299(5): 847-852

[19] KreuterR., SoutarA.K., WadeD.P.. Transcription factors CCAAT/enhancer-binding protein beta and nuclear factor-Y bind to discrete regulatory elements in the very low density lipoprotein receptor promoter. J Lipid Res, 1999, 40(3): 376-386

[20] EnslerK., MohammadiehM., BroijersenA., et al. . Dexamethasone stimulates very low density lipoprotein (VLDL) receptor gene expression in differentiating 3T3-L1 cells. Biochim Biophys Acta, 2002, 1581(1–2): 36-48

[21] WoodJ.L., RussoA.F.. Autoregulation of cell-specific MAP kinase control of the tryptophan hydroxylase promoter. J Biol Chem, 2001, 276(24): 21 262-21 271

[22] CaivanoM., CohenP.. Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1 beta in RAW264 macrophages. J Immunol, 2000, 164(6): 3018-3025

[23] WangC.B., FengY.M., ZongY.Q., et al. . Rapid isolation of large amount of plasma VLDL and LDL by a two step ultracentrifugation. J Tongji Med Univ, 1995, 15(4): 198-200

[24] QuS., YangS., YouY., et al. . Construction of eukaryotic expression vector pBLacZ and its expression both in vivo and in vitro. J Tongji Med Univ, 1996, 16(1): 14-17

[25] SuzukiJ., TakahashiS., OidaK., et al. . Lipid accumulation and foam cell formation in Chinese hamster ovary cells overexpressing very low density lipoprotein receptor. Biochem Biophys Res Commun, 1995, 206(3): 835-842

[26] KosakaS., TakahashiS., MasamuraK., et al. . Evidence of macrophage foam cell formation by very low-density lipoprotein receptor: interferon-gamma inhibition of very low-density lipoprotein receptor expression and foam cell formation in macrophages. Circulation, 2001, 103(8): 1142-1147